Heterocyclic compound
US-10428056-B2 · Oct 1, 2019 · US
Process methods for phosphatidylinositol 3-kinase inhibitors
US10414737B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10414737-B2 |
| Application number | US-201816025862-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 2, 2018 |
| Priority date | Dec 20, 2013 |
| Publication date | Sep 17, 2019 |
| Grant date | Sep 17, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound intermediates relating to these processes are also disclosed.
First claim
Opening claim text (preview).
The invention claimed is: 1. A process for synthesizing a compound of formula (II): or a salt thereof, comprising combining a compound of formula (14): or a salt thereof, and one or more reagents to remove the amino protective group tetrahydropyranyl (THP) from…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10414737B2 cover?
- A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound intermediates relating to these processes are also disclosed.
- Who is the assignee on this patent?
- Gilead Calistoga Llc, Gilead Sciences Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D265/22. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).